Key statistics
On Friday, PharmaEssentia Corp (8Z1:FRA) closed at 15.50, 0.00% below its 52-week high of 15.50, set on Jan 16, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 0.00 |
|---|---|
| High | 15.50 |
| Low | 15.50 |
| Bid | -- |
| Offer | -- |
| Previous close | 15.50 |
| Average volume | -- |
|---|---|
| Shares outstanding | -- |
| Free float | -- |
| P/E (TTM) | -- |
| Market cap | -- |
| EPS (TTM) | -- |
Data delayed at least 15 minutes, as of Jan 16 2026 08:46 GMT.
More ▼
Press releases
- PharmaEssentia Announces Plans to Establish New U.S. Manufacturing Facility in Puerto Rico to Support Global Growth of BESREMi®
- PharmaEssentia Announces Updated NCCN Clinical Practice Guidelines Include ropeginterferon alfa-2b-njft (BESREMi®) for Treatment of Essential Thrombocythemia (ET)
- FDA Confirms a PDUFA Goal Date of August 30, 2026 for the sBLA Submission of Ropeginterferon Alfa-2b-njft in Essential Thrombocythemia (ET)
- PharmaEssentia Announces Positive Topline Phase 2b Data from EXCEED-ET Study Evaluating Ropeginterferon Alfa-2b-njft for Essential Thrombocythemia
- PharmaEssentia USA Announces Appointment of Jeffrey Williams as Independent Director
- PharmaEssentia Announces Presentation at J.P. Morgan Healthcare Conference and Strategic Priorities for 2026
- PharmaEssentia Announces Publication of Phase 3 SURPASS-ET Results in The Lancet Haematology
- PharmaEssentia Announces Presentations at ASH 2025
More ▼
